Symposium:
90. Novel Insights into Fungal Pathogenesis
Thursday, October 27, 2016: 2:00 PM-3:30 PM
Room: 278-282
Co-organized with the National Institute of Allergy and Infectious Diseases

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • describe the unique features and challenges associated with mucormycosis relative to other mold infections in the clinic
  • recognize the mechanisms by which Rhizopus invades host cells and causes lethal disease
  • to review the mechanisms by which neutrophils and monocytes/macrophages protect against inhaled mold fungi

Target Audience: Academicians, Clinicians, Fellows, Infectious diseases pediatricians, Infectious diseases physicians, Investigators, Members-in-training, Microbiologists, Pharmacists, Researchers, Scientists, Vaccinologists

Tracks: Pediatric ID, Investigative ID, Adult ID

Moderators:  Michail Lionakis, MD, ScD, National Institute of Allergy and Infectious Diseases (NIAID) and Eleftherios Mylonakis, MD, PhD, FIDSA, Rhode Island Hospital and Warren Alpert Medical School of Brown University

Presentations:
2:00 PM
826
An Update on Mucormycosis in the Clinic
Dimitrios P. Kontoyiannis, MD, ScD, FIDSA

2:25 PM
Q&A
2:30 PM
827
Novel Translational Development into the Pathogenesis of Mucormycosis at the Bench
Ashraf S. Ibrahim, PhD

2:55 PM
Q&A
3:00 PM
828
An Overview of Innate Host Defense Mechanisms Against Inhaled Mold Infection
Tobias M. Hohl, MD, PhD, FIDSA

3:25 PM
Q&A

CME Credits: Maximum of 1.5 hours of AMA PRA Category 1 Credit™

ACPE Credits: ACPE 1.5 knowledge-based contact hours 0.15 of pharmacy CE

ACPE Number: 0221-9999-16-231-L01-P

Disclosures:

M. Lionakis, Viamet: Collaborator , Research support

E. Mylonakis, None

See more of: Symposium
<< Previous Session | Next Session >>

Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.